These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11264572)

  • 21. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver fibrosis and inflammation. A review.
    Kershenobich Stalnikowitz D; Weissbrod AB
    Ann Hepatol; 2003; 2(4):159-63. PubMed ID: 15115954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases, the pros and cons, in liver fibrosis.
    Han YP
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3(Suppl 3):S88-91. PubMed ID: 16958682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liver fibrosis and cirrhosis--causes. Part I].
    Wirkowska A; Paczek L
    Przegl Lek; 2011; 68(4):222-7. PubMed ID: 21853678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-matrix interactions in schistosomal portal fibrosis: a dynamic event.
    Grimaud JA
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():55-65. PubMed ID: 3334433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
    Parola M; Pinzani M
    Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
    Gressner AM; Bachem MG
    Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and liver fibrosis (translational aspects).
    Roeb E
    Matrix Biol; 2018 Aug; 68-69():463-473. PubMed ID: 29289644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation.
    Mak KM; Chen LL; Lee TF
    Anat Rec (Hoboken); 2013 Jun; 296(6):953-64. PubMed ID: 23596149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of liver fibrosis: role of oxidative stress.
    Poli G
    Mol Aspects Med; 2000 Jun; 21(3):49-98. PubMed ID: 10978499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
    Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
    Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol-associated capillarization of sinusoids: A critique since the discovery by Schaffner and Popper in 1963.
    Mak KM; Kee D; Shin DW
    Anat Rec (Hoboken); 2022 Jul; 305(7):1592-1610. PubMed ID: 34766732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of hepatic fibrogenesis].
    Lamireau T; Desmoulière A; Bioulac-Sage P; Rosenbaum J
    Arch Pediatr; 2002 Apr; 9(4):392-405. PubMed ID: 11998427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver fibrosis.
    Wallace K; Burt AD; Wright MC
    Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.
    Rockey DC; Chung JJ
    J Clin Invest; 1996 Sep; 98(6):1381-8. PubMed ID: 8823303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular mechanisms in liver fibrogenesis.
    Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
    Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.